The Biotech Growth Trust PLC (BIOG)

Category Sector Equity Biotechnology
star-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

867.00p

Buy

879.00p

arrow-up2.00p (+0.23%)

Discount/Premium

-10.23%

Estimated NAV

962.449p

Prices updated at 24 Dec 2024, 12:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
FTSE All-Share
arrow-up0.47%
LSE
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Portfolio as of 30/11/2024

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Top 10 holdings

1
Amgen Inc
Sector
-
Country
United States
% of assets
9.09059
2
QuantumPharm Inc
Sector
-
Country
China
% of assets
5.68969
3
Sarepta Therapeutics Inc
Sector
-
Country
United States
% of assets
5.06769
4
Biogen Inc
Sector
-
Country
United States
% of assets
4.52025
5
Gilead Sciences Inc
Sector
-
Country
United States
% of assets
4.46218
6
Ionis Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
3.80719
7
Regeneron Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
3.58076
8
argenx SE ADR
Sector
-
Country
United States
% of assets
3.45854
9
Alnylam Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
3.23145
10
Phathom Pharmaceuticals Inc Ordinary shares
Sector
-
Country
United States
% of assets
2.97686
Assets in top 10 holdings %

45.89%

Total no. of equity holdings

64.00

Total no. of bond holdings

-

Stock sectors

The Biotech Growth Trust PLC
Sector Equity Biotechnology

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

100.00%

Con defensive

-
-

Healthcare

100.00%
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2024 Morningstar. All rights reserved.